case report | Q2782326 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1110028793 |
P356 | DOI | 10.1186/S40360-018-0267-5 |
P932 | PMC publication ID | 6245888 |
P698 | PubMed publication ID | 30454022 |
P50 | author | Trygve Holmøy | Q64539783 |
P2093 | author name string | Gisle Bjerke | |
Svetozar Zarnovicky | |||
Aija Zuleron Myro | |||
P2860 | cites work | Diffuse alveolar hemorrhage | Q84155719 |
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use | Q26849781 | ||
Bicuspid Aortic Valve: a Review with Recommendations for Genetic Counseling | Q28080091 | ||
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial | Q30053056 | ||
Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis | Q35737068 | ||
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis | Q37337775 | ||
Monoclonal antibody-induced cytokine-release syndrome | Q37755276 | ||
Acute infusion reactions induced by monoclonal antibody therapy | Q37821495 | ||
Pulmonary toxicities from targeted therapies: a review | Q37955066 | ||
The immunological function of CD52 and its targeting in organ transplantation | Q38747419 | ||
Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS. | Q39744600 | ||
Diffuse Alveolar haemorrhage: a fatal complication after alemtuzumab induction therapy in renal transplantation. | Q40171238 | ||
Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis | Q48196935 | ||
Diffuse alveolar hemorrhage following alemtuzumab | Q48431558 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | multiple sclerosis | Q8277 |
diffuse alveolar hemorrhage | Q55788710 | ||
P304 | page(s) | 75 | |
P577 | publication date | 2018-11-19 | |
P1433 | published in | BMC pharmacology & toxicology | Q27724429 |
P1476 | title | Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report | |
P478 | volume | 19 |
Search more.